February 29th, 2012 by UCSDMedicalCenter
This video introduces Dr. Santosh Kesari and his patient. UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a San Diego Company, Tocagen Inc. "This clinical trial targets glioblastoma — one of the deadliest forms of brain tumor" said principal investigator Santosh Kesari, MD, PhD, Director of Neuro-Oncology in the Moores Cancer Center and in the Department of Neurosciences at the University of California, San Diego. "Clinical trials of investigational therapies such as this may lead to new treatment options for patients battling this deadly disease." The current standard of care for a newly diagnosed, high-grade glioma includes surgically removing as much of the tumor as possible, followed by radiation therapy and chemotherapy. Despite these measures, the tumor usually recurs making this trial a high priority. The trial is investigating the use of Toca 511 (vocimagene amiretrorepvec), for injection in combination with Toca FC (flucytosine), extended-release tablets. Toca 511 is a retroviral replicating vector (RRV) that is designed to deliver a cytosine deaminase (CD) gene selectively to cancer cells. After allowing time for the administered Toca 511 to spread through the cancerous tumor those cancer cells expressing the CD gene can convert flucytosine into the anti-cancer drug <b>…</b>
February 29th, 2012 by UCSDMedicalCenter
This video introduces Dr. Santosh Kesari and his patient. UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a San Diego Company, Tocagen Inc. "This clinical trial targets glioblastoma — one of the deadliest forms of brain tumor" said principal investigator Santosh Kesari, MD, PhD, Director of Neuro-Oncology in the Moores Cancer Center and in the Department of Neurosciences at the University of California, San Diego. "Clinical trials of investigational therapies such as this may lead to new treatment options for patients battling this deadly disease." The current standard of care for a newly diagnosed, high-grade glioma includes surgically removing as much of the tumor as possible, followed by radiation therapy and chemotherapy. Despite these measures, the tumor usually recurs making this trial a high priority. The trial is investigating the use of Toca 511 (vocimagene amiretrorepvec), for injection in combination with Toca FC (flucytosine), extended-release tablets. Toca 511 is a retroviral replicating vector (RRV) that is designed to deliver a cytosine deaminase (CD) gene selectively to cancer cells. After allowing time for the administered Toca 511 to spread through the cancerous tumor those cancer cells expressing the CD gene can convert flucytosine into the anti-cancer drug <b>…</b>
February 29th, 2012 by ViaChristiHealth
February 29th, 2012 by WeAreFightingCancer
Agility is the next generation, high resolution beam shaping solution from Elekta. Built on a strong understanding of the factors that are critical to patient plan optimization and treatment delivery, Agility is designed to meet the needs of modern rad…
February 29th, 2012 by WeAreFightingCancer
Agility is the next generation, high resolution beam shaping solution from Elekta. Built on a strong understanding of the factors that are critical to patient plan optimization and treatment delivery, Agility is designed to meet the needs of modern rad…
February 29th, 2012 by PhillyCyberKnife
Philadelphia CyberKnife treats prostate cancer using stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation precisely aimed from different angles. Philadelphia CyberKnife treats several different types of malignant …
February 29th, 2012 by InformaticsMD
Holy Hippocrates…This is nihilism at its finest. This is what happens when “education” turns into madness. Infanticide of newborns becomes a right:The TelegraphFeb. 29, 2012http://www.telegraph.co.uk/health/healthnews/9113394/Killing-babies-no-diff…
February 29th, 2012 by AFMSCEMMTube
In general, the treatment may include surgery to remove some combination of organs and tissues. If both of the ovaries and the fallopian tubes are removed, the procedure is called a salpingo-oophorectomy. If the uterus is removed, the procedure is call…
February 29th, 2012 by AFMSCEMMTube
The majority of women with uterine cancer are treated with a hysterectomy, a surgery that removes the uterus either through the vagina or through an incision in the abdomen. In most cases, the surgeon will also remove both fallopian tubes and both ovar…
February 29th, 2012 by AFMSCEMMTube
Surgery is the primary treatment used most often for breast cancer. The techniques that are used include breast-sparing surgery, modified radical mastectomy, and in fewer cases, radical mastectomy. For more information please visit www.breastdiseasesat…